Seminars in Oncology

Article	Citations
TOC	73
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis	58
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance	32
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review	29
Editorial Board	25
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics	21
Role of neoadjuvant pembrolizumab in advanced melanoma	21
Military exposures and lung cancer in United States Veterans	16
Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer	14
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans	14
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations	14
Adenocarcinoma on retrorectal cystic hamartoma: An illustrative image for a very rare diagnosis	13
Editorial Board	13
Masthead	13
The Impact of HIV on Non-AIDS defining gastrointestinal malignancies: A review	12
Liquid Biopsy, the hype vs. hope in molecular and clinical oncology	11
The interest of therapeutic and pharmacological drug monitoring of methotrexate: A systematic review	11
Immune checkpoint inhibitors in patients with chronic kidney disease: Assessing their ability to cause acute kidney injury and informing their proper use	10
Masthead	10
The knowns and unknowns of disparities, biology, and clinical outcomes in Hispanic and Latinx multiple myeloma patients in the U.S.	10
Masthead	10
Assessment of PSA responses and changes in the rate of tumor growth -rate with immune checkpoint inhibitors in US Veterans with prostate cancer	10
Treatment and outcomes of pediatric patients with cancer and COVID-19 at MAHAK pediatric cancer treatment and research center, Tehran, Iran	9
Impact of the COVID-19 Pandemic on the Wellbeing of International Oncology and Hematology Fellows at the Princess Margaret Cancer Center (PMCC)	9
Acute liver failure secondary to malignant infiltration: A single center experience	9

The challenges of selecting cancer medicines for the WHO Essential Medicines List with the elephant in the room: A path forward	8
Biomarkers and the microbiome in the detection and treatment of early-stage non-small cell lung cancer	8
Barriers and facilitators to lung cancer screening and follow-up	8
Editorial Board	8
Screening Adherence for Second Primary Malignancies in Breast Cancer Survivors: Behaviors, Facilitators, and Barriers to Enhance Quality Care	8
Masthead	7
Treating patients with dihydropyrimidine dehydrogenase (DPD) deficiency with fluoropyrimidine chemotherapy since the onset of routine prospective testing—The experience of a large oncology center in t	7
Surgery for early-stage lung cancer with video-assisted thoracoscopic surgery versus open thoracotomy: A narrative review	7
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects	6
High tumor mutation burden mitigates the negative impact of chemotherapy history on immune checkpoint blockade therapy	6
Current and prospective antibody-based therapies in multiple myeloma	6
outside front cover	6
Radiation recall dermatitis: A review of the literature	6
A narrative review of the principal glucocorticoids employed in cancer	6
outside front cover	6
Editorial Board	6
Treating advanced lung cancer in older Veterans with comorbid conditions and frailty	5
Masthead	5
Managing multiple myeloma in a resource-limited region: Diagnosis and treatment in Armenia	5
Colorectal cancer in Ethiopia: Epidemiological trends, diagnostic and laboratory capacities, and challenges	5
Landmark trials in the medical oncology management of metastatic breast cancer	5
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety	5
Advances and challenges in cancer immunotherapy: Strategies for personalized treatment	5
Daratumumab: A review of current indications and future directions	5
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data	5
Comorbidity and life expectancy in shared decision making for lung cancer screening	4
outside front cover	4
The impact of the COVID-19 pandemic on tertiary care cancer center: Analyzing administrative data	4
Communication strategies during the COVID-19 pandemic: Unforeseen opportunities and drawbacks	4
PARP inhibitors in ovarian cancer	4
TOC	4
Masthead	4
Table of Contents	4
Outcomes with panobinostat in heavily pretreated multiple myeloma patients	4
Assessing Outcomes in NSCLC: Radiomic analysis, kinetic analysis and circulating tumor DNA	4
Outside front cover	3
Lung cancer screening at the VA: Past, present and future	3
Fingerprint change as a consequence of anticancer treatments: A systematic integrative review	3
The dual effect of interferon-γ in acute myeloid leukemia: A narrative review	3
Table of Contents	3
TOC	3
Examining health related quality of life outcomes in multiple myeloma: Past and future perspectives	3
outside front cover	3
Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis	3
Outside front cover	3
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review	3
Current perspectives, guiding lights to the future, and transforming care for patients with multiple myeloma	3
Which future for de-intensified treatments in HPV-related oropharyngeal carcinoma?	2
Scoping to analyze oncology trial participation in Australia	2
Non-small cell lung cancer in the era of immunotherapy	2

Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias	2
TOC	2
Editorial Board	2
The critical role of NLRP3 in drug resistance of cancers: Focus on the molecular mechanisms and possible therapeutics	2
Divergent functions of TLRs in gastrointestinal (GI) cancer: Overview of their diagnostic, prognostic and therapeutic value	2
Editorial Board	2
A review of immune checkpoint blockade in breast cancer	1
Implications of reactive oxygen species on cancer formation and its treatment	1
Overcoming barriers to opioid-induced constipation management in cancer patients	1
TOC	1
Table of Contents	1
Lung cancer: Premalignant biology and medical prevention	1
Editorial Board	1
The Crucial Nexus: Unveiling the Role of Collagen in Cancer Progression	1
TOC	1
Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents	1
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management	1
Outside front cover	1
Epidemiology and genetics of early onset colorectal cancer—African overview with a focus on Ethiopia	1
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis	1
outside front cover	0
Editorial Board	0
Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review	0
PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics	0
Obesity correlates to the microsatellite instability of endometrial cancer: A retrospective observational study	0
Practice change: No benefit of extended lymphadenectomy at radical cystectomy in patients with muscle invasive bladder cancer	0
From doctors to ancillary staff: Regional and metropolitan cancer workforce perceptions and distress resulting from COVID-19 pandemic adaptations	0
Loss of function STK11 alterations and poor outcomes in non–small-cell lung cancer: Literature and case series of US Veterans	0
outside front cover	0
Masthead	0
Editorial Board	0
Mechanistic role of FTO in cancer pathogenesis, immune evasion, chemotherapy resistance, and immunotherapy response	0
Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized con	0
Breast cancer care: Looking for the new normal	0
Integrated profile of tumor stage and mutational burden predicts disparate clinical responses to immune checkpoint inhibitors: A risk-benefit study	0
Predictors of treatment refusal in patients with colorectal cancer: A systematic review	0
Exploring the clinical trials, regulatory insights, and challenges of PROTACs in oncology	0
Harnessing natural killer cells for the treatment of multiple myeloma	0
Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer	0
Masthead	0
Seminars in oncology 50th anniversary	0
Gender-based differences in the efficacy of anti-EGFR/BRAF/MEK targeted therapy in patients with BRAF-mutated metastatic colorectal cancer	0
Advancements and implications of artificial intelligence for early detection, diagnosis and tailored treatment of cancer	0
Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients	0
NTRK fusion-positive cancer in nonagenarian patient. The importance of comprehensive geriatric assessment in older people for the inclusion in clinical trials	0
IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time	0
Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program	0
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab	0
Real-world experience with CDK4-6 inhibition in the old and oldest old with a diagnosis of breast cancer	0
Cancer stage and time from cancer diagnosis to first treatment during the COVID-19 pandemic	0
Tumor testing and treatment patterns in veterans with metastatic castration-resistant prostate cancer	0
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action	0
Pathogenic signaling in multiple myeloma	0
Table of Contents	0
Chemotherapy-induced peripheral neuropathy and rehabilitation: A review	0
Editorial Board	0
Masthead	0
TOC	0
TOC	0
Battling chronic myeloid leukemia in a resource-constrained country: A case of public-private partnerships	0
Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?	0
Impact of CT screening in lung cancer: Scientific evidence and literature review	0
Exploring the effects of racial and socioeconomic factors on timeliness of lung cancer diagnosis and treatment in Baltimore Veterans	0
Practical guidance for new multiple myeloma treatment regimens: A nursing perspective	0
Editorial Board	0
PARP inhibitors for prostate cancer	0
outside front cover	0
PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance	0
RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain	0
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment	0
Editorial Board	0
Circular RNAs: Emerging regulators of signaling pathways in epithelial-mesenchymal transition and angiogenesis during breast cancer progression	0
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.	0
outside front cover	0
COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature	0
Pioneering the Future of Oncology: A New Vision for Seminars in Oncology	0
Torticollis as a presenting symptom of pediatric CNS tumors: A systematic review	0
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancer	0
Editorial Board	0
Improving the efficacy of immunotherapy in small cell lung cancer: Leveraging recent scientific discoveries and tumor-specific antigens	0

Efficacy of memantine in preventing neurocognitive dysfunction induced by radiation therapy in patients with brain metastases: A systematic review of clinical trials	0
Deep Myometrial Infiltration leads to a measurable Inflammatory Response in Endometrial Cancer. A Prospective Observational Study	0
Epidemiology and prevention of gastric cancer: A comprehensive review	0
Skin metastases in the clinical and dermoscopic aspects	0
Non-pharmacologic interventions for improving cancer-related fatigue (CRF): A systematic review of systematic reviews and pooled meta-analysis	0
Lung Cancer Screening and Precision Oncology	0
Importance, relevance, and pertinence of discussing mental health in the uro-oncology patient	0
Masthead	0
Masthead	0
Table of Contents	0
CAR T-cell therapy: A collaboration between authorized treatment centers and community oncologists	0
The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma	0
TOC	0
Chemotherapy plus immunotherapy as first line combination in older patients with extensive stage small cell lung cancer: A systematic review and meta-analysis	0
Plant polyphenols in gastric cancer: Nature's healing touch	0
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis	0
Editorial Board	0
“Off-the-shelf” immunotherapies for multiple myeloma	0
Complete response in a frail patient with high-grade B-cell lymphoma to only one cycle of R-CHOP or to prolonged COVID-19?	0
Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy?	0
Defining genomic events involved in the evolutionary trajectories of myeloma and its precursor conditions	0
outside front cover	0
Masthead	0
Controversies and challenges in lung cancer screening	0
Masthead	0
TOC	0
Masthead	0
Editorial Board	0
The flaws in assessing and reporting the toxicities of oral targeted therapies	0
Modern radiographic imaging in multiple myeloma, what is the minimum requirement?	0
The likelihood of being helped or harmed obtained from clinical trial results for cancer therapy: Can it really help?	0
Molecular biomarkers and liquid biopsies in lung cancer	0
A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective	0
Novel targeted therapies for advanced non-small lung cancer	0
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease	0
The psychosocial and emotional experiences of cancer patients during the COVID-19 pandemic: A systematic review	0
outside front cover	0
Masthead	0
Outside front cover	0
Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701)	0
Liquid biopsy: An innovative tool in oncology. Where do we stand?	0
Challenges in initiating a lung cancer screening program: Experiences from two VA medical centers	0